University of Chicago Medicine, USA
Wendy Stock, MD
Dr. Stock obtained her BS in biology from the University of Illinois, a MA in zoology from the University of California, Davis and graduated from Rush Medical College in 1985. From 1985-1988, she was a resident in Internal Medicine at the University of Chicago and completed her hematology-oncology fellowship at the University of Chicago in 1993. Dr. Stock is a tenured Professor of Medicine where she led the leukemia program at the University of Chicago for 19 years and where she was also a co-leader of the University of Chicago Comprehensive Cancer Center’s Program in Hematopoiesis and Hematological Malignancies. At a national level, she currently serves as co-chair of the Leukemia and Leukemia Clinical and Correlative Sciences Committees in the Alliance, a NCI-sponsored clinical trials cooperative group that leads national and international trials in leukemia clinical research, and recently completed a term as the first chair of the NCI national clinical trials network (NCTN) Leukemia Steering committee, the committee which sets the agenda for all NCI sponsored large phase II and III trials in leukemia in the United States.
Dr. Stock is an expert in clinical and correlative laboratory research involving acute leukemias. Her focus has been to design biologically risk-adapted clinical trials for patients with acute leukemias, leading national trials for treatment of acute lymphoblastic leukemia (ALL) that have helped to change the standard of care for young adults with this disease. Dr. Stock has also established a young adult leukemia clinic at the University of Chicago which she runs jointly with her pediatric colleagues and which is committed to providing innovative research trials and clinical care to this patient population. She has focused on identifying new biological prognostic factors in specific subsets of leukemia that lead to novel clinical trial design and has focused particularly on the clinical significance of molecular detection and monitoring of subclinical disease (or minimal residual disease) using quantitative molecular methods.
Dr. Stock has published more than 200 peer-reviewed papers, reviews and book chapters and serves as Associate Editor of the new journal of the American Society of Hematology, Blood Advances. She also served on the American Board of Internal Medicine hematology board that prepares the board certification examination in hematology. She has received a number of awards including the Gold DOC award for humanism in medicine, and is listed as a “Top Doctor” by both Chicago magazine, Newsweek magazine and US News and World Report. In 2014, she was awarded an endowed chair, the Anjuli Seth Nayak Chair for Leukemia Research, by the University of Chicago. She has received a number of mentorship awards including the Arthur Rubinstein Mentorship award from the University of Chicago department of Medicine, the Department of Medicine Resident teaching award, and the Distinguished Clinician award from the Biological Sciences Division of the University of Chicago. Dr. Stock recently received the “Researcher of the Year” award from the Illinois chapter of the Leukemia and Lymphoma Society of America and a director’s scientific leadership award by the National Cancer Institute.